The expression of PD-1 was low or absent in the spleen of both treatments (Supplementary Fig. 7c), while NKTR-214 enhanced activation of T cells in tumor in the mice treated with ACT + NKTR-214 (Supplementary Fig. 7d). Here, NKTR is linked to neoplasm.